<p>Vandana Patravale of the Institute of Chemical Technology in India will develop a sub-unit nanovaccine using green technology against brucellosis, a zoonotic disease which is endemic in sub-Saharan West Africa. The vaccine will be developed for non-invasive intranasal administration and the investigators will study vaccine delivery and its ability to induce a strong protective immune response against Brucella in mice, with a view to future clinical testing in humans.</p>


Vandana Patravale of the Institute of Chemical Technology in India will develop a sub-unit nanovaccine using green technology against brucellosis, a zoonotic disease which is endemic in sub-Saharan West Africa. The vaccine will be developed for non-invasive intranasal administration and the investigators will study vaccine delivery and its ability to induce a strong protective immune response against Brucella in mice, with a view to future clinical testing in humans.

Nanovaccine for Brucellosis Using Green Technology

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.